Casciato: Manual of Clinical Oncology 6th edition

The Manual of Clinical Oncology, which has attained major popularity as a reference source for oncology fellows, residents, and medical students, is completely revised for its sixth edition. Like its predecessors, it focuses on information useful for making diagnostic and therapeutic decisions at the bedside of patients with cancer. The goal for the Manual has been to remain comprehensive, current, and concise, without being susceptible to rapid obsolescence. Redundancy is not allowed. Evanescent aspects of oncology, such as chemotherapy “regimens of the month,” have been assiduously avoided.

The chapters are grouped into four parts.

• Part I presents the principles of diagnosis and treatment of cancer. 
• Parts II and III address the specific malignancies in a uniform format. 
• Part IV presents complications of cancer according to end-organ involvement, whether by local invasion, metastasis, paraneoplasia, or therapy. 

The Appendices present:

• cytogenetic nomenclature (Appendix A); 
• the complications of chemotherapy and toxicity criteria for evaluating patients in clinical trials (Appendix B); 
• tumor identifiers, such as immuno-histochemical differential diagnosis, leukocyte differentiation antigens, and the World Health Organization’s classifications of hematopoietic malignancies (Appendix C); and 
• the most useful chemotherapeutic regimens for lymphomas (Appendix D).

This sixth edition of the Manual of Clinical Oncology reaffirms the unique relationship between patient and doctor and continues its commitment to provide the caregiver with the ability to temper today’s popular interventions with good judgment and a cautious open-mindedness to the promise of tomorrow.
Manual of Clinical Oncology 6th edition by Dennis A. Casciato and Mary C. Territo is a practical, accessible, comprehensive guide to the management of patients with cancer. In an outline format designed for rapid reference, the book provides the essential information needed for fast, effective clinical decision-making at the bedside. Coverage begins with principles of cancer management, proceeds through the specific malignancies, and then focuses on the organ-specific complications of cancer, whether due to the disease or its treatments. The unique appendices permit better readability within the chapters by placing frequently referenced, large, complex, and detailed tables at the end of the book. The appendices present cytogenetic nomenclature, toxicity of chemotherapy, critical tumor identifiers, and combination chemotherapy regimens for lymphomas.

Contents
PART I: GENERAL ASPECTS

• Chapter 1 Principles, Definitions, and Statistics
• Chapter 2 Nuclear Medicine
• Chapter 3 Radiation Oncology
• Chapter 4 Cancer Chemotherapeutic Agents
• Chapter 5 Supportive Care
• Chapter 6 Talking with Cancer Patients and Their Families

PART II: SOLID TUMORS

• Chapter 7 Head and Neck Cancers
• Chapter 8 Lung Cancer
• Chapter 9 Gastrointestinal Tract Cancers
• Chapter 10 Breast Cancer
• Chapter 11 Gynecologic Cancers
• Chapter 12 Testicular Cancer
• Chapter 13 Urinary Tract Cancers
• Chapter 14 Neurological Tumors
• Chapter 15 Endocrine Neoplasms
• Chapter 16 Skin Cancers
• Chapter 17 Sarcomas
• Chapter 18 Cancers in Childhood
• Chapter 19 Miscellaneous Neoplasms
• Chapter 20 Metastases of Unknown Origin

PART III: HEMATOPOIETIC MALIGNANCIES

• Chapter 21 Hodgkin and Non-Hodgkin Lymphoma
• Chapter 22 Plasma Cell Dyscrasias and WaldenstrÖm's Macroglobulinemia
• Chapter 23 Chronic Leukemias
• Chapter 24 Myeloproliferative Disorders
• Chapter 25 Acute Leukemia and Myelodysplastic Syndromes

PART IV: COMPLICATIONS

• Chapter 26 Sexual Function and Pregnancy
• Chapter 27 Metabolic Complications
• Chapter 28 Cutaneous Complications
• Chapter 29 Thoracic Complications
• Chapter 30 Abdominal Complications
• Chapter 31 Renal Complications
• Chapter 32 Neuromuscular Complications
• Chapter 33 Bone and Joint Complications
• Chapter 34 Hematologic Complications
• Chapter 35 Infectious Complications
• Chapter 36 AIDS-Related Malignancies
• Chapter 37 Hematopoietic Stem Cell Transplantation

Appendix A Glossary of Cytogenetic Nomenclature
Appendix B Toxicity of Chemotherapy

• B1. Major Toxicities and Dose Modifications for Antineoplastic Agents
• B2. Abridged Common Toxicity Criteria

Appendix C Tumor Identifiers

• C1. Microscopic Clues of Tumor Origin
• C2. Selected Immunohistochemical Tumor Markers
• C3. Immunohistochemistry Diagnostic Algorithms
• C4. Expected Immunophenotypes of Tumors
• C5. Discriminatory Immunophenotypes for Lymphocytic Neoplasms
• C6. Classification of Lymphoproliferative Disorders
• C7. Acute Leukemias: Classification, Cytology, Cytochemistry, and Cytometry>

Appendix D Combination Chemotherapy Regimens for Lymphomas

• D1. Regimens for Hodgkin Lymphoma (HL)
• D2. Regimens for Non-Hodgkin Lymphoma (NLH)
• D3. Salvage Regimens for Hodgkin and Non-Hodgkin Lymphoma

Index 



Book Details

• Paperback: 832 pages
  
• Publisher: Lippincott Williams & Wilkins; 6 edition (2009)
  
• Language: English
  
• ISBN-10: 0781768845
  
• ISBN-13: 9780781768849
  
• Product Dimensions: 8.2 x 5.2 x 1.1 inches
  

List Price: $61.95